Format

Send to

Choose Destination
Vaccine. 2010 May 7;28(21):3633-4. doi: 10.1016/j.vaccine.2010.03.025. Epub 2010 Mar 26.

Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: response to misleading comments in Ranganathan et al. "recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice".

PMID:
20347058
DOI:
10.1016/j.vaccine.2010.03.025
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center